A carregar...
Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
Primary immune thrombocytopenia (ITP) is a bleeding disorder that conventionally has been treated with steroids or other immunosuppressive treatments. The introduction of thrombopoietin receptor agonists (TPO-RAs), which increase platelet production, dramatically changed the treatment landscape for...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6515841/ https://ncbi.nlm.nih.gov/pubmed/31156798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719837906 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|